AstraZeneca and Hall & Partners are delighted to have won the ‘Best Use of Innovation’ award in the coveted the 2021 BHBIA BOBI Awards. The healthcare research project, which leveraged innovative technology to speed insights to action across a globally distributed team, was initially recognised as ‘Highly Commended’ in the ‘Best use of Innovation’ category.
The BHBIA BOBI judges described the winning healthcare innovation project as “never seen before”, as they paid reference to how the partnership with AstraZeneca brought the “market research to life” on what was described as a “topical need” which was “well demonstrated”.
‘Best use of innovation’ submission summary:
AstraZeneca had achieved unprecedented clinical trial outcomes which, as a result, accelerated their launch plan by two years. The leading pharmaceutical and biotechnology company needed to test and optimise their global launch campaign fast. Recognising the challenges – a rapidly approaching launch, tight timings, and diverse stakeholder needs, alongside the background of virtual working due to COVID-19 – AstraZeneca challenged Hall & Partners to reimagine the insights sharing and synthesis process.
Hall & Partners constructed an innovative approach which centred on The Hub – an in-house data discovery, knowledge management and insight storytelling platform. This cutting-edge insight platform brought agility, efficiency, and alignment, letting AstraZeneca make insight-led decisions confidently and at speed.
What are the BHBIA BOBI Awards?
Organised by BHBIA, the BOBI Awards recognise excellence across the healthcare business intelligence spectrum.
Who were the finalists?
HRW and AbbVie
Red Leaf & Sanofi